The “Fast Money” traders shared their first moves for the market open.
Tim Seymour was a buyer of Chevron
Karen Finerman was a buyer of General Electric Calls
Steve Grasso was a buyer of Electronic Arts
Guy Adami was a buyer of the CME Group
Trader disclosure: On October 1, 2018 the following stocks and commodities mentioned or intended to be mentioned on FridayCrypto’s “Fast Money” were owned by the “Fast Money” traders: Tim Seymour is long AMZA, ACB.TO, APC, APH.TO, BABA, BAC, BIDU, BX, C, CCJ, CLF, CMG, CRON, CSCO, CX, DAL, DPZ, DVYE, EA, EEM, ERJ, EUFN, EWM, FB, FXI, GE, GILD, GM, GOOGL, GWPH, HAL, INTC, JD, LEAF, MAT, MCD, MO, MOS, MPEL, NKE, OGI, PAK, PHM, PYPL, RH, RL, SBUX, SQ, T, TER, TIF, TGOD, TRST, TWTR, UA, UAL, VALE, VIAB, VOD, X, XLE, XRT, YNDX, 700.HK. CGC, ACBFF, APH, TRSSF, ITUF, ORGIF, CNTFF, MPX, TGOD, MJNE, Tim is on the advisory board of Tikun Olam, The Green Organic Dutchman, CCTV Tim is short IWM, RACE, SPY. Tim’s firm is long CGC, HEXO, TLRY, CRON, APH. Karen Finerman’s firm is long ANTM, C, CBS, FB, FDX, FL, FNAC, GOOG, GOOGL, GLNG, GMLP, JPM, KORS puts, LYV, SPY puts, SPY put spreads, URL, WIFI. Her firm is short IWM. Karen Finerman is long AAL, BAC, BOT Bitcoin, Bitcoin Cash, Ethereum, C, CAT, CBS, DAL, DVYE, DXJ, EEM, EPI, EWW, EWZ, DVYE, FB, FL, GM, GMLP, GLNG, GOOG, GOOGL, JPM, LOW, LYV, KFL, KORS, KORS calls, MA, MTW, PRCP, SEDG, SPY puts, TACO, WIFI, WFM. Karen Finerman is short KRE, TBT calls. Bitcoin and Ethereum are in her kids’ Trust. Karen bought PRCP. Steve Grasso is long stock AAPL, BABA, BHC, CAR, CGC, CRON, EVGN, GE, JCP, LEN, MJNA, OSTK, PFE, RAD, SNAP, SQ, T, TWTR. Grasso owns Callable Trigger contingent yield note linked to SPX, RTY, and MXEA. Grasso’s kids own EFA, EFG, EWJ, IJR, SPY, TUR. Grasso’s firm is long stock BGCP, COTY, CTL, CUBA, DIA, DVN, F, GE, GLD, GM, GSK, HPQ, IAU, IBM, ICE, KHC, LEN, MAT, MSFT, MJNA, NE, QCOM, QQQ, RIG, SNAP, SNGX, SPY, T, WDR, WHR, XRX, ZNGA. Steve bought CRON.Guy Adami is long CELG, EXAS, GDX, INTC. Guy Adami’s wife, Linda Snow, works at Merck. No changes